Marcan Pharmaceuticals
Canada-based pharmaceutical company that develops, registers, manufactures, distributes and commercializes branded and generic finished-dose medicines for the Canadian market. Publishes a public product roster and professional product listing with Drug Identification Numbers (DINs), therapeutic class, pack formats and downloadable bilingual product monographs and patient information leaflets. Maintains finished-dose portfolios spanning oral solid dosage forms and hospital sterile injectables (including lyophilized powders), operates patient support programs, manages adverse-event reporting and pharmacovigilance, and provides an API catalog with regulatory dossier status indicators. Publishes supplier compliance and forced-labour prevention policies.
Industries
Nr. of Employees
small (1-50)
Marcan Pharmaceuticals
Products
Hospital-use sterile injectables portfolio
Range of sterile injectable products supplied in vials and kits, including liquid injectables and lyophilized powders designed for parenteral administration in hospital settings across multiple therapeutic classes (including antineoplastics and antibiotics).
Extensive generic oral solid dose portfolio
Large roster of generic oral tablets, capsules and ODTs across therapeutic classes with multiple strengths, pack sizes and downloadable bilingual monographs.
API supply and sourcing catalog
Public listing and provision of active pharmaceutical ingredients with indicated regulatory dossier statuses to support formulation and contract manufacturing.
Hospital-use sterile injectables portfolio
Range of sterile injectable products supplied in vials and kits, including liquid injectables and lyophilized powders designed for parenteral administration in hospital settings across multiple therapeutic classes (including antineoplastics and antibiotics).
Extensive generic oral solid dose portfolio
Large roster of generic oral tablets, capsules and ODTs across therapeutic classes with multiple strengths, pack sizes and downloadable bilingual monographs.
API supply and sourcing catalog
Public listing and provision of active pharmaceutical ingredients with indicated regulatory dossier statuses to support formulation and contract manufacturing.
Services
Manufacture and nationwide distribution of oral and injectable finished-dose products across multiple therapeutic areas and packaging formats; supply to retail and hospital pharmacies.
Preparation and electronic publication of bilingual product monographs and patient information leaflets to support product registration and HCP/patient communication.
Published API catalog with regulatory dossier status indicators to support formulation and contract manufacturing selection and procurement.
Maintained professional-page product listing for clinicians and pharmacists showing DINs, strengths, formats and links to full product details for procurement and clinical reference.
Manufacture and nationwide distribution of oral and injectable finished-dose products across multiple therapeutic areas and packaging formats; supply to retail and hospital pharmacies.
Preparation and electronic publication of bilingual product monographs and patient information leaflets to support product registration and HCP/patient communication.
Published API catalog with regulatory dossier status indicators to support formulation and contract manufacturing selection and procurement.
Maintained professional-page product listing for clinicians and pharmacists showing DINs, strengths, formats and links to full product details for procurement and clinical reference.
Expertise Areas
- Generic drug development and commercialization
- Sterile injectable and lyophilized product manufacturing and supply
- Oral solid dose formulation and packaging
- API sourcing and regulatory dossier coordination
Key Technologies
- Oral solid dosage formulation (tablets, capsules, orally disintegrating tablets)
- Sterile injectable formulation and aseptic filling
- Lyophilization for sterile powders
- Regulatory dossier tracking (DMF/ASMF/CEP equivalents)
News & Updates
National product launches of cyclophosphamide injectable presentations across Canada.
Public statement and supplier compliance expectations on forced labour and child labour prevention, including anti-forced-labour contractual clauses and supplier monitoring.
Joint annual report made available in downloadable PDF format.
Acquired in 2015 by a vertically integrated global manufacturer and R&D organization, enabling optimization of product development and supply.
Company acquisition expanding portfolio.
National product launches of cyclophosphamide injectable presentations across Canada.
Public statement and supplier compliance expectations on forced labour and child labour prevention, including anti-forced-labour contractual clauses and supplier monitoring.
Joint annual report made available in downloadable PDF format.
Acquired in 2015 by a vertically integrated global manufacturer and R&D organization, enabling optimization of product development and supply.
Company acquisition expanding portfolio.